Edition:
United States

Mettler-Toledo International Inc (MTD.N)

MTD.N on New York Stock Exchange

671.86USD
19 Feb 2019
Change (% chg)

$3.00 (+0.45%)
Prev Close
$668.86
Open
$666.47
Day's High
$673.22
Day's Low
$666.47
Volume
32,711
Avg. Vol
41,198
52-wk High
$673.41
52-wk Low
$500.74

Summary

Name Age Since Current Position

Robert Spoerry

63 2009 Chairman of the Board

Oliver Filliol

52 2009 President, Chief Executive Officer, Director

Shawn Vadala

50 2014 Chief Financial Officer

Peter Aggersbjerg

50 2018 Head of Laboratory

Marc de la Gueronniere

55 2014 Head of European and North American Market Organizations

Michael Heidingsfelder

58 2012 Head of Industrial

Gerhard Keller

51 2018 Head of Process Analytics

Simon Kirk

59 2012 Head - Product Inspection

Christian Magloth

52 2010 Head - Human Resources

Elisha W. Finney

56 2017 Director

Wah-Hui Chu

66 2007 Independent Director

Richard Francis

51 2016 Independent Director

Constance Harvey

57 2015 Independent Director

Michael Kelly

61 2008 Independent Director

Hans Maerki

72 2002 Independent Director

Thomas Salice

58 2010 Presiding Independent Director

Mary Finnegan

Treasurer / Investor Relations

Biographies

Name Description

Robert Spoerry

Mr. Robert F. Spoerry is Chairman of the Board of the Company. He has been Chairman of the Board of Directors of the company since May 1998. He has a Master’s in Mechanical Engineering from the Federal Institute of Technology in Zurich, Switzerland, and a Master of Business Administration from the University of Chicago. Mr. Spoerry was President and Chief Executive Officer of the company from 1993 to 2007 and served as its Executive Chairman in 2008. Mr. Spoerry is also a Director of Conzzeta Holding AG, and Sonova Holding AG, where he has served as Chairman since March 2011. Mr. Spoerry was previously a Director of Geberit AG, from 2009 to April 2016. As the former President and CEO of the company, Mr. Spoerry has long-standing experience in the global precision instrument industry and a deep knowledge of the company, including its organization, products, markets, customers, and competitors. He has a strong technical background and experience with innovation-driven companies. Mr. Spoerry has broad international experience across industries and businesses relevant to the company, including by virtue of his service on several other boards of directors.

Oliver Filliol

Mr. Oliver A. Filliol is President, Chief Executive Officer, Director of the Company. He has been a director since January 2009. He has been President and Chief Executive Officer of the Company since January 1, 2008. Mr. Filliol served as Head of Global Sales, Service, and Marketing of the Company from April 2004 to December 2007 and Head of Process Analytics of the Company from June 1999 to December 2007. From June 1998 to June 1999, he served as General Manager of the Company’s U.S. checkweighing operations. Prior to joining the Company, he was a Strategy Consultant with the international consulting firm Bain & Company, working in the Geneva, Paris, and Sydney offices.

Shawn Vadala

Mr. Shawn P. Vadala is Chief Financial Officer of the Company. He joined the Company in 1997 and has been Chief Financial Officer since January 2014, and also responsible for the Company's Pricing program since 2008. Mr. Vadala previously held various senior financial positions at the Company's Columbus, Ohio and Greifensee, Switzerland offices and was also responsible for Business Intelligence from 2010 to 2018. Prior to joining the Company, he worked in the Boston and Zurich, Switzerland offices of PricewaterhouseCoopers.

Peter Aggersbjerg

Mr. Peter Aggersbjerg is Head of Laboratory of the Company. From February 2016 to December 2017, he served as the Head of our Laboratory Weighing strategic business unit. He served as the Global BU Head for Medela's Neonatal Care business and a member of its Group management from February 2011 until joining the Company in February 2016. Prior to Medela, Mr. Aggersbjerg was CEO for Swissimplant from July 2010 to February 2011, Vernal from October 2006 to December 2008, and Tytex from October 2001 to October 2006.

Marc de la Gueronniere

Mr. Marc de la Gueronniere is Head of European and North American Market Organizations of the Company. He has been Head of European Market Organizations of the Company since January 2008 and Head of North American Market Organizations since April 2014. He was Head of Region South and General Manager of the Company’s market organization in Spain from January 2006 to January 2008. He joined the Company in 2001 as the Industrial Business Area Manager for our market organization in France. Prior to joining the Company, Mr. de La Guéronnière held various management positions in Europe and the United States with ABB-Elsag Bailey and Danaher-Zellweger.

Michael Heidingsfelder

Mr. Michael Heidingsfelder is Head of Industrial of the Company. He joined the Company in April 2012 as Head of Industrial Division. Prior to joining the Company, Mr. Heidingsfelder held various management positions within the Freudenberg Group from 2004 to March 2012 in Europe, Asia, and the Americas, including Chief Operating Officer, Americas, and General Manager, China. Previously, he was a Partner of Roland Berger Strategy Consultants in the U.S. and Europe.

Gerhard Keller

Mr. Gerhard Keller is Head of Process Analytics of the Company. He joined the Company in 1991 and has been Head of Process Analytics since July 2018 and Head of Pipettes since July 2013. He previously was Head of Region East Asia/Pacific and has also served in various Sales and Marketing leadership functions in Europe and Asia Pacific. Prior to joining the Company, he worked in Quality Control at Sandoz, now Novartis, in Switzerland.

Simon Kirk

Mr. Simon Kirk is Head - Product Inspection of the Company. He joined the Company in January 2012 as Head of Product Inspection. Previously, he worked at Schindler where he served since 2008 as Chief Executive Officer of Jardine Schindler Group, a joint venture responsible for all of Schindler's operations in Southeast Asia. From 2004 until 2008, he was Vice President responsible for Eastern Europe at Schindler. He has also held various management positions at Eaton Corporation, Owens Corning, Imperial Chemical Industries, and British Railways Board.

Christian Magloth

Mr. Christian Magloth is Head - Human Resources of the Company. He joined the Company in October 2010 and has been Head of Human Resources since December 2010. Prior to joining the Company, he served as Head of Human Resources of Straumann, a leading global medical devices company listed on the Swiss stock exchange, from April 2006 to September 2010. He previously served as Head of Human Resources at Hero Group, an international consumer foods company, and in various management positions at Hilti, a leading global construction supply company.

Elisha W. Finney

Ms. Elisha W. Finney is a director of the METTLER-TOLEDO INTERNATIONAL INC. since November 2017. She serves on the Audit Committee and, after the Annual Meeting of Shareholders for 2018, will serve as its Chair. She has a Bachelor’s of Business Administration in Risk Management and Insurance from the University of Georgia, and Master’s in Business Administration from Golden Gate University. Ms. Finney is a Director and member of the Audit Committees of NanoString Technologies, Inc., iRobot Corporation, ICU Medical, Inc., and Cutera, Inc., and Chairs the Audit Committees of ICU Medical and Cutera. She previously was a director of Altera Corporation until December 2015, and Thoratec Corporation until May 2013. Ms. Finney was the Chief Financial officer of Varian Medical Systems Inc. from 1999 until her retirement in June 2017. She joined Varian in 1988 and served in a variety of finance roles prior to her appointment as CFO. Ms. Finney is an experienced CFO. Under her financial leadership, Varian achieved and sustained decades-long growth in revenues and profitability. She also has significant leadership and corporate governance experience from her time at Varian, and her service on other boards of directors.

Wah-Hui Chu

Mr. Wah-Hui Chu is an Independent Director of the Company. He serves on the Nominating and Corporate Governance Committee. He has a Master’s in Business Administration from Roosevelt University. In 2013, Mr. Chu served as Chief Executive Officer of Tingyi Asahi Beverages, the largest soft drink company in China with over $6 billion in revenue, and was its Executive Director until February 2014. He served as a Director of Li Ning Company Limited from July 2007 through December 2012; and was Executive Director and Chief Executive Officer of Next Media Limited, the leading publicly traded media company in Hong Kong that focuses on the greater China region, from October 2008 to October 2011. He also served as Chairman of PepsiCo Investment (China) Limited from January 1999 to March 2007 and again from March 2012 to December 2013. Mr. Chu spent many years as an executive at PepsiCo, serving as: non-executive Chairman of PepsiCo International’s Asia Region from April 2007 to April 2008; and President of PepsiCo International — China Beverages Business Unit from March 1998 to March 2007.

Richard Francis

Mr. Richard D. Francis is an Independent Director of the Company. He has a Bachelor of Arts in Economics from the Manchester Metropolitan University. He has been Division Head and Chief Executive Officer of Sandoz, the Generics Division of Novartis, since 2014. Prior to his current position, Mr. Francis spent 13 years at Biogen Idec, where he held various global and country leadership positions. Immediately prior to leaving Biogen in 2014, Mr. Francis was Senior Vice President of their US Commercial organization. From 1998 to 2001, he held various marketing roles at Sanofi. Mr. Francis has in-depth knowledge of the generics, pharmaceutical, and biotechnology industry sectors, which are important market segments for the company. He also has significant leadership and international expertise and will provide useful insights to our global organization.

Constance Harvey

Ms. Constance L. Harvey is no longer Independent Director of the Company, effective May 2019. She serves on the Nominating and Corporate Governance Committee. She has a Bachelor of Science in Industrial Engineering from Iowa State University. Ms. Harvey was an executive with Conduent (formerly Xerox Services) since 2001, most recently serving as Chief Operating Officer, Commercial Healthcare Business Group starting in 2014 and Vice President starting in 2012. She held both positions until her retirement in January 2017. Prior to that she served as Chief Operating Officer for Commercial Business Process Outsourcing starting in 2011, and before that Group President of the healthcare payer and insurance delivery unit. In her role at Conduent, Ms. Harvey developed strong leadership experience. Her group encompassed service offerings for the healthcare industry including payers, providers, and pharmaceutical and life science companies, some of which are key end-user markets for the company. She also has significant experience in relevant topics, including business process engineering and building a service business through organic growth and mergers and acquisitions.

Michael Kelly

Mr. Michael A. Kelly is an Independent Director of the Company. He serves on the Audit and Compensation Committees. He has completed executive education at The Wharton School of the University of Pennsylvania. He is a Director of HERC Holdings Inc. Mr. Kelly spent many years as an executive at 3M Company, serving as Executive Vice President of the Electronics and Energy Business from October 2012 to January 2016, and Executive Vice President of the Display and Graphics Business from October 2006 to October 2012. He served in various management positions in the U.S., Singapore, Korea, and Germany since he joined 3M in 1981.

Hans Maerki

Mr. Hans Ulrich Maerki is no longer Independent Director of the Company, effective May 2019. He serves on the Compensation Committee and as Chairman of the Nominating & Corporate Governance Committee. He has a Master’s in Business Administration from the University of Basel, Switzerland, and a 2010 Senior Fellowship of Advanced Leadership at Harvard University. Mr. Maerki spent many years as an executive at IBM, serving as the: Chairman of IBM Europe/Middle East/Africa (EMEA) from August 2001 to March 2008; Chief Executive Officer of IBM EMEA from July 2003 to May 2005; General Manager of IBM Global Services, EMEA from 1996 to July 2001; and various other positions at IBM beginning in 1973. He was a director at ABB Ltd. for 12 years, from 2002 until 2014, and at Swiss Re for nine years, from 2007 to March 2016. In his 35-year tenure at IBM, including ultimately running a business with approximately $35 billion in revenue across 124 countries, Mr. Maerki has made extensive contributions in addressing service, software, and other IT-related topics, and also has deep experience in marketing and sales. These are areas of increasing importance to the company’s business, and as a result this experience is very relevant. By virtue of his service on the board of ABB, Mr. Maerki also had insight into the industrial end-user market, which is another key market for the company.

Thomas Salice

Mr. Thomas P. Salice is Presiding Independent Director of the Company. He is considered one of the board’s financial experts, and serves on the Audit Committee and as Chairman of the Compensation Committee. He has a Master’s in Business Administration from Harvard University. Mr. Salice is a co-founder, principal, and Managing Member of SFW Capital Partners, LLC, a private equity firm. He is a Director of Waters Corporation and the privately-held companies Essen Bioscience, Inc., Filtec, Gerson Lehrman Group, and Spectro Scientific Inc. Mr. Salice has been a Managing Member of SFW Capital Partners since January 2005. From June 1989 to December 2004, he served in a variety of capacities with AEA Investors, Inc., including Managing Director, President and Chief Executive Officer, and Vice-Chairman.

Mary Finnegan